AHA and member hospitals yesterday told a federal court that court-ordered targets for reducing the backlog of Medicare appeals at the Administrative Law Judge level remain crucial for ensuring a maintenance of effort by the Department of Health and Human Services. U.S. District Judge James Boasberg focused yesterday’s hearing on deadline-based remedies for addressing the backlog given that the agency’s latest court filings project elimination of the backlog by fiscal year 2022. Government counsel argued that court-ordered reduction targets are now unnecessary because of additional agency funding to expand adjudicatory capacity and the reduced volume of Recovery Audit Contractor-related appeals currently entering the system. An appeals court last year rescinded a court order previously obtained by AHA and the hospitals that required HHS to clear the backlog within five years, but left the district court free to reinstate the same requirement if HHS fails to demonstrate it is “impossible” to comply. Counsel for the AHA and the hospitals urged the court also to consider additional measures to alleviate hardships from the backlogged appeals while further progress is made. Judge Boasberg expects to issue his decision soon. 

Perspective
Public
Approximately 35 million Americans are enrolled in Medicare Advantage plans in 2026, and that number is expected to grow to about 45 million MA enrollees by…
Headline
The Centers for Medicare & Medicaid Services has released details on downloading its upcoming fiscal year 2025 Program for Evaluating Payment Patterns…
Headline
The Department of Health and Human Services Administration for Community Living has launched the first phase of its Health at Home Challenge, a competition to…
Headline
The AHA shared the following statement with the media in response to a report released May 7 by Families USA.   “This report is long on rhetoric and…
Headline
The AHA May 7 wrote to House and Senate lawmakers in support of the Medicare Advantage Improvement Act (H.R. 8375/S. 4384), bipartisan and bicameral…
Headline
The Centers for Medicare & Medicaid Services announced May 6 that it will provide access to certain glucagon-like peptide-1 (GLP-1) medications to eligible…